首页> 外文OA文献 >Is early virological response as predictive of the hepatitis C treatment response in dialysis patients as in non-uremic patients?
【2h】

Is early virological response as predictive of the hepatitis C treatment response in dialysis patients as in non-uremic patients?

机译:和非尿毒症患者一样,早期病毒学应答是否可预测透析患者的丙型肝炎治疗应答?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: the aim of the present study was to determine whether hepatitis C virus (HCV) RNA present at week 12 is a good predictor of the response to interferon (IFN) monotherapy in hemodialysis patients with hepatitis C.Methods: Hemodialysis patients with hepatitis C who were treated between 1997 and 2008 with IFN monotherapy for 48 weeks without dose reduction were included. the predictive value of HCV RNA at week 12 for achieving a sustained virological response (SVR) was determined.Results: Forty patients (mean age 47 +/- 9 years; 75% males and 80% with genotype 1) were included. Septal fibrosis or cirrhosis was observed in 38% of these patients. Twelve (30%) of the 40 patients achieved SVR. HCV RNA was undetectable at week 12 in 68%. the positive predictive value of HCV RNA at week 12 was 45% and the negative predictive value was 100%.Conclusions: the presence of HCV RNA at week 12 had a high negative predictive value for SVR in hemodialysis patients with chronic hepatitis C treated with IFN for 48 weeks. Therefore, if HCV RNA is detected at week 12, treatment should be discontinued due to the low probability of a sustained response. (0 2012 International Society for Infectious Diseases. Published by Elsevier B.V. All rights reserved.
机译:目的:本研究的目的是确定第12周出现的丙型肝炎病毒(HCV)RNA是否能很好地预测丙型肝炎血液透析患者对干扰素(IFN)单药治疗的反应。方法:丙型血液透析患者纳入1997年至2008年之间接受IFN单药治疗48周且未降低剂量的研究对象。结果:确定了40名患者(平均年龄47 +/- 9岁;男性75%,基因型1的80%)在第12周时的HCV RNA对实现持续病毒学应答(SVR)的预测价值。在这些患者中,有38%的患者出现中隔纤维化或肝硬化。 40名患者中有12名(30%)达到了SVR。 HCV RNA在第12周未检测到68%。结论:在接受IFN治疗的慢性丙型肝炎血液透析患者中​​,HCV RNA在第12周时的阳性预测值为45%,阴性预测值为100%。结论:在第12周时,HCV RNA的存在对SVR具有较高的SVR阴性预测值持续48周。因此,如果在第12周检测到HCV RNA,则由于持续应答的可能性低,应中止治疗。 (0 2012国际传染病学会。ElsevierB.V.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号